Kadmon Pharms Llc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for KADMON PHARMS LLC, and what generic alternatives to KADMON PHARMS LLC drugs are available?
KADMON PHARMS LLC has one approved drug.
There are five US patents protecting KADMON PHARMS LLC drugs.
There are forty-three patent family members on KADMON PHARMS LLC drugs in twenty-nine countries.
Summary for Kadmon Pharms Llc
International Patents: | 43 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Kadmon Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 10,696,660 | See Plans and Pricing | See Plans and Pricing | ||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 9,815,820 | See Plans and Pricing | See Plans and Pricing | ||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 11,311,541 | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kadmon Pharms Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2014055996 | See Plans and Pricing |
Australia | 2006230159 | See Plans and Pricing |
Finland | 2903618 | See Plans and Pricing |
Portugal | 2903618 | See Plans and Pricing |
European Patent Office | 1865958 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.